Denali Therapeutics Inc. Voting Outcome
Historical shareholder voting results from retained filings, including every disclosed proposal and director nominee. Vote counts are as filed, not split-adjusted, and displayed in K/M/B/T. — means the category was not reported or no vote was held. Frequency votes preserve each choice. All retained years remain available through pagination.
| Meeting / report date | Proposal / nominee | Outcome | For (shares) | Against (shares) | Abstain (shares) | Withheld (shares) | Broker non-votes (shares) | Filed | Frequency choices (shares) | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |